The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - BeiGene; Bristol-Myers Squibb; Five Prime Therapeutics; Incyte; Kite, a Gilead company; Nektar; Novartis; Tesaro
Pharmacodynamics (PD) and genomic profiling of pts treated with cabiralizumab (cabira) + nivolumab (NIVO) provide evidence of on-target tumor immune modulations and support future clinical applications.
 
Michael Carleton
No Relationships to Disclose
 
Janine Powers
Employment - Five Prime Therapeutics; Five Prime Therapeutics
Stock and Other Ownership Interests - Pfizer
Patents, Royalties, Other Intellectual Property - multiple patents for FGFRs in hair growth
 
Penny Phillips
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Other Relationship - Celgene (I)
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Celgene; Genentech/Roche; Guardant Health; Ipsen; Merrimack
Speakers' Bureau - Genentech/Roche; Ipsen
Research Funding - Agios (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck Serono (Inst)
 
James J. Lee
Consulting or Advisory Role - Incyte; Loxo
Research Funding - Incyte; Merck
 
Osama E. Rahma
Honoraria - Clinical Care Options; Merck; MI Bioresearch
Consulting or Advisory Role - Alcimed; Celgene; Five Prime Therapeutics; Gfk; Merck; Merck; Putnam Associates
Research Funding - Amgen (Inst); Merck
Travel, Accommodations, Expenses - Clinical Care Options; Merck
 
Sarina Anne Piha-Paul
Consulting or Advisory Role - Genentech
Research Funding - Abbvie; Bayer; BlueLink; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; MedImmune; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Pieris Pharmaceuticals; Principa Biopharma; Puma Biotechnology; Tesaro; XuanZhu
 
Ernestine Lee
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Ke Xu
Employment - Five Prime Therapeutics
Leadership - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics
 
Dimple Pandya
Employment - Bristol-Myers Squibb
 
Sandeep P. Inamdar
Employment - Acerta Pharma; Onyx
Stock and Other Ownership Interests - Amgen; Gilead Sciences; GlaxoSmithKline; Onyx
 
Serena K Perna
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Shih-Min A. Huang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Roche
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
Other Relationship - Bristol-Myers Squibb; Roche
 
Zev A. Wainberg
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Five Prime Therapeutics; Genentech; Lilly; Merck; Merck KGaA; Novartis; Sirtex Medical
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech